Skip to main content

Advertisement

Log in

The “North German Tumor Bank of Colorectal Cancer”: status report after the first 2 years of support by the German Cancer Aid Foundation

  • Original Article
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Purpose

Research projects and clinical trials strongly rely on high-quality biospecimens which are provided by biobanks. Since differences in sample processing and storage can strongly affect the outcome of such studies, standardization between biobanks is necessary to guarantee reliable results of large, multicenter studies. The German Cancer Aid Foundation (Deutsche Krebshilfe e.V.) has therefore initiated the priority program “tumor tissue banks” in 2010 by funding four biobank networks focusing on central nervous system tumors, melanomas, breast carcinomas, and colorectal carcinomas. The latter one, the North German Tumor Bank of Colorectal Cancer (ColoNet) is managed by surgeons, pathologists, gastroenterologists, oncologists, scientists, and medical computer scientists.

Methods and results

The ColoNet consortium has developed and harmonized standard operating procedures concerning all biobanking aspects. Crucial steps for quality assurance have been implemented and resulted in certification according to DIN EN ISO 9001. A further achievement is the construction of a web-based database for exploring available samples. In addition, common scientific projects have been initiated. Thus, ColoNet’s repository will be used for research projects in order to improve early diagnosis, therapy, follow-up, and prognosis of colorectal cancer patients. Apart from the routine sample storage at −170 °C, the tumor banks’ unique characteristic is the participation of outpatient clinics and private practices to further expand the sample and clinical data collection.

Conclusion

The first 2 years of funding by the German Cancer Aid Foundation have already led to a closer scientific connection between the participating institutions and to a substantial collection of biospecimens obtained under highly standardized conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Sotiriou C, Piccart MJ (2007) Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care? Nat Rev Cancer 7(7):545–553. doi:10.1038/nrc2173

    Article  PubMed  CAS  Google Scholar 

  2. Marko-Varga G (2011) Biobanking—the holy grail of novel drug and diagnostic developments? J Clin Bioinforma 1(1):14. doi:10.1186/2043-9113-1-14

    Article  PubMed  Google Scholar 

  3. Hewitt R, Hainaut P (2011) Biobanking in a fast moving world: an international perspective. J Natl Cancer Inst Monogr 2011(42):50–51. doi:10.1093/jncimonographs/lgr005

    Article  PubMed  Google Scholar 

  4. Hewitt RE (2011) Biobanking: the foundation of personalized medicine. Curr Opin Oncol 23(1):112–119. doi:10.1097/CCO.0b013e32834161b8

    Article  PubMed  Google Scholar 

  5. Gaffney EF, Madden D, Thomas GA (2012) The human side of cancer biobanking. Methods Mol Biol 823:59–77. doi:10.1007/978-1-60327-216-2_5

    Article  PubMed  CAS  Google Scholar 

  6. Stege A, Hummel M (2008) Experience with establishment and operation of a biobank. Der Pathologe 29(Suppl 2):214–217. doi:10.1007/s00292-008-1043-x

    Article  PubMed  Google Scholar 

  7. Bevilacqua G, Bosman F, Dassesse T, Hofler H, Janin A, Langer R, Larsimont D, Morente MM, Riegman P, Schirmacher P, Stanta G, Zatloukal K, Caboux E, Hainaut P (2010) The role of the pathologist in tissue banking: European Consensus Expert Group Report. Virchows Arch Int J Pathol 456(4):449–454. doi:10.1007/s00428-010-0887-7

    Article  Google Scholar 

  8. Asslaber M, Zatloukal K (2007) Biobanks: transnational, European and global networks. Brief Funct Genomic Proteomic 6(3):193–201. doi:10.1093/bfgp/elm023

    Article  PubMed  Google Scholar 

  9. Betsou F, Lehmann S, Ashton G, Barnes M, Benson EE, Coppola D, DeSouza Y, Eliason J, Glazer B, Guadagni F, Harding K, Horsfall DJ, Kleeberger C, Nanni U, Prasad A, Shea K, Skubitz A, Somiari S, Gunter E (2010) Standard preanalytical coding for biospecimens: defining the sample PREanalytical code. Cancer Epidemiol Biomarkers Prev: A Publ Am Assoc Cancer Res, Cosponsored by the Am Soc Prev Oncol 19(4):1004–1011. doi:10.1158/1055-9965.EPI-09-1268

    Article  CAS  Google Scholar 

  10. Vegvari A, Welinder C, Lindberg H, Fehniger TE, Marko-Varga G (2011) Biobank resources for future patient care: developments, principles and concepts. J Clin Bioinforma 1(1):24. doi:10.1186/2043-9113-1-24

    Article  PubMed  Google Scholar 

  11. Riegman PH, Morente MM, Betsou F, de Blasio P, Geary P (2008) Biobanking for better healthcare. Mol Oncol 2(3):213–222. doi:10.1016/j.molonc.2008.07.004

    Article  PubMed  Google Scholar 

  12. Schmitt M, Mengele K, Schueren E, Sweep FC, Foekens JA, Brunner N, Laabs J, Malik A, Harbeck N (2007) European Organisation for Research and Treatment of Cancer (EORTC) Pathobiology Group standard operating procedure for the preparation of human tumour tissue extracts suited for the quantitative analysis of tissue-associated biomarkers. Eur J Cancer 43(5):835–844. doi:10.1016/j.ejca.2007.01.008

    Article  PubMed  CAS  Google Scholar 

  13. Linnebacher M, Maletzki C, Ostwald C, Klier U, Krohn M, Klar E, Prall F (2010) Cryopreservation of human colorectal carcinomas prior to xenografting. BMC Cancer 10:362. doi:10.1186/1471-2407-10-362

    Article  PubMed  Google Scholar 

  14. Betsou F, Luzergues A, Carter A, Geary P, Riegman P, Clark B, Morente M, Vaught J, Dhirr R, Druez-Vérité C (2007) Towards norms for accreditation of biobanks for human health and medical research: compilation of existing guidelines into an ISO certification/accreditation norm-compatible format. Qual Assur J 11(3–4):221–294. doi:10.1002/qaj.425

    Article  Google Scholar 

  15. Carter A, Betsou F, Clark BJ (2011) Quality management and accreditation of research tissue banks. Virchows Arch Int J Pathol 458(2):247–248. doi:10.1007/s00428-010-1028-z, author reply 249–250

    Article  Google Scholar 

  16. Gerling M, Meyer KF, Fuchs K, Igl BW, Fritzsche B, Ziegler A, Bader F, Kujath P, Schimmelpenning H, Bruch HP, Roblick UJ, Habermann JK (2010) High frequency of aneuploidy defines ulcerative colitis-associated carcinomas: a comparative prognostic study to sporadic colorectal carcinomas. Ann Surg. doi:10.1097/SLA.0b013e3181deb664

  17. Pantel K, Alix-Panabieres C (2010) Circulating tumour cells in cancer patients: challenges and perspectives. Trends Mol Med 16(9):398–406. doi:10.1016/j.molmed.2010.07.001

    Article  PubMed  Google Scholar 

  18. Vegas H, Andre T, Bidard FC, Ferrand FR, Huguet F, Mariani P, Pierga JY (2012) Disseminated and circulating tumor cells in gastrointestinal oncology. Bull Cancer 99(5):535–544. doi:10.1684/bdc.2012.1581

    PubMed  Google Scholar 

  19. Reng CM, Debold P, Specker C, Pommerening K (2006) Generische Lösungen zum Datenschutz für die Forschungsnetze in der Medizin. TMF Schriftenreihe. Medizinisch Wissenschaftliche Verlagsgesellschaft

  20. Murphy S, Churchill S, Bry L, Chueh H, Weiss S, Lazarus R, Zeng Q, Dubey A, Gainer V, Mendis M, Glaser J, Kohane I (2009) Instrumenting the health care enterprise for discovery research in the genomic era. Genome Res 19(9):1675–1681. doi:10.1101/gr.094615.109

    Article  PubMed  CAS  Google Scholar 

  21. Murphy SN, Weber G, Mendis M, Gainer V, Chueh HC, Churchill S, Kohane I (2010) Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2). J Am Med Inform Assoc: JAMIA 17(2):124–130. doi:10.1136/jamia.2009.000893

    Article  PubMed  Google Scholar 

  22. Prokosch HU, Ries M, Beyer A, Schwenk M, Seggewies C, Kopcke F, Mate S, Martin M, Barthlein B, Beckmann MW, Sturzl M, Croner R, Wullich B, Ganslandt T, Burkle T (2011) IT infrastructure components to support clinical care and translational research projects in a comprehensive cancer center. Stud Health Technol Inform 169:892–896

    PubMed  Google Scholar 

  23. Mate S, Burkle T, Kopcke F, Breil B, Wullich B, Dugas M, Prokosch HU, Ganslandt T (2011) Populating the i2b2 database with heterogeneous EMR data: a semantic network approach. Stud Health Technol Inform 169:502–506

    PubMed  Google Scholar 

Download references

Acknowledgments

The tumor biobank consortium “North German Tumor Bank of Colorectal Cancer” is generously supported by the German Cancer Aid Foundation (DKH e.V. #108446).

Conflicts of interest

None.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Jens K. Habermann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oberländer, M., Linnebacher, M., König, A. et al. The “North German Tumor Bank of Colorectal Cancer”: status report after the first 2 years of support by the German Cancer Aid Foundation. Langenbecks Arch Surg 398, 251–258 (2013). https://doi.org/10.1007/s00423-012-1043-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-012-1043-4

Keywords

Navigation